• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE XPEDITION 48 EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE XPEDITION 48 EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1070300-48
Device Problems Deflation Problem (1149); Difficult to Remove (1528); Material Separation (1562); Improper or Incorrect Procedure or Method (2017)
Patient Problem Insufficient Information (4580)
Event Date 05/06/2021
Event Type  Injury  
Manufacturer Narrative
(b)(4).The device is retained by the facility.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Event Description
It was reported that the procedure was to treat the heavily calcified, moderately tortuous, 100% stenosed right coronary artery.The patient presented with myocardial infarction and occlusion in the right coronary artery.The 3.0x48 mm xience xpedition stent was implanted and after implant, it was found that the balloon of the stent delivery system (sds) would not completely deflate.There was resistance during removal, force was used and upon further manipulation, the balloon detached from the delivery system.The patient was sent to coronary artery bypass graft (cabg) surgery and the balloon was removed.No additional information was provided.
 
Event Description
Subsequent to the initially filed report the following information was provided: the procedure was to treat the mid right coronary artery (rca) with moderate calcification, no tortuosity and 100% stenosis with thrombotic occlusion.The stent balloon was inflated once to 16 atmospheres (atm) and negative pressure was held for 60-70 seconds to deflate the balloon.No additional information was provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The investigation was unable to determine a conclusive cause for the reported deflation problem; however, factors that may contribute to deflation problems include, but are not limited to, contamination in the inflation lumen, patient anatomical morphology, patient disease state, deflation technique, contrast dilution, and inadequate connection to the deflation device.It is likely the partially deflated balloon interacted with the difficult anatomy and/or procedural device accessories during removal causing the reported difficulty to remove.The xience xpedition instructions for use (ifu) lists the steps of re-inflation of the balloon to nominal pressure and re-performing the removal procedure section for withdrawal when resistance is felt during removal of the stent delivery system.It should be noted, the device was not re-inflated per the instructions listed in the ifu.Instead, force was applied after resistance was noted during removal resulting in the reported material separation and subsequent surgical intervention, removal of a foreign body and hospitalization.There is no indication of a product quality issue with respect to manufacture, design or labeling.H6: medical device problem code 2017 clarifier was updated from "excessive force" to "failure to follow steps/instructions".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE XPEDITION 48 EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key11874229
MDR Text Key252317848
Report Number2024168-2021-04365
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 06/22/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/25/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date08/29/2022
Device Catalogue Number1070300-48
Device Lot Number9082241
Was Device Available for Evaluation? No
Date Manufacturer Received06/01/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
Patient Age45 YR
Patient Weight80
-
-